Ceapro (TSXV:CZO) Additional Paid-In Capital : C$4.96 Mil(As of Dec. 2023)

View and export this data going back to 1992. Start your Free Trial

What is Ceapro Additional Paid-In Capital?

Ceapro's quarterly additional paid-in capital increased from Jun. 2023 (C$4.91 Mil) to Sep. 2023 (C$4.94 Mil) and increased from Sep. 2023 (C$4.94 Mil) to Dec. 2023 (C$4.96 Mil).

Ceapro's annual additional paid-in capital increased from Dec. 2021 (C$4.68 Mil) to Dec. 2022 (C$4.71 Mil) and increased from Dec. 2022 (C$4.71 Mil) to Dec. 2023 (C$4.96 Mil).

Ceapro Additional Paid-In Capital Historical Data

The historical data trend for Ceapro's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ceapro Additional Paid-In Capital Chart

Ceapro Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

4.65

4.68

4.71

4.96

Ceapro Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															4.71	4.85	4.91	4.94	4.96

Ceapro Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Ceapro Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Ceapro's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Ceapro (TSXV:CZO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ceapro Inc (TSXV:CZO) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

CRPOF:USA

Address

7824-51 Avenue NW, Edmonton, AB, CAN, T6E 6W2

Website

https://www.ceapro.com

Ceapro Inc is engaged in the development and marketing of various health and wellness products and technology relating to plant extracts. Its operating segment is the active ingredient product technology industry which involves the development of proprietary extraction technologies and the application of these technologies to the production and development and commercialization of active ingredients derived from oats and other renewable plant resources for healthcare and cosmetic industries. Active ingredients produced include oat beta glucan and avenanthramides. The group derives revenue from the U.S., Germany, China, Canada and other countries, of which prime revenue is generated from the U.S.

Ceapro (TSXV:CZO) Headlines

No Headlines